Related Experiment Video
Updated: Apr 25, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS
Alice Trentalange1, Andrea Calcagno, Stefania Raviolo
1Unit of Infectious Diseases, Department of Medical Sciences, University of Torino, ASLTO2, Torino, Italy. alicetrenta@gmail.com.
Insights
Diagnosing cytomegalovirus (CMV) central nervous system (CNS) disease in HIV patients is challenging due to mimicking symptoms and comorbidities. CMV CNS replication can occur with undetectable plasma CMV DNA, requiring careful monitoring and treatment.
Area of Science:
- Neuroscience
- Infectious Diseases
- Virology
Background:
- Cytomegalovirus (CMV) central nervous system (CNS) involvement is rare and difficult to diagnose, often presenting with symptoms mimicking other neurological conditions.
- Human immunodeficiency virus (HIV)-positive individuals are susceptible to opportunistic infections, including CMV, which can affect the CNS.
Observation:
- A case study of an HIV-positive patient with neurological symptoms (headache, confusion, ataxia) and multiple concurrent opportunistic diseases (neurotoxoplasmosis, Kaposi's sarcoma, CMV infection).
- CMV CNS involvement was initially overlooked due to the patient's complex comorbidities and the absence of detectable CMV DNA in plasma.
- Cerebrospinal fluid (CSF) analysis revealed a high CMV viral load (31,340 copies/ml) despite undetectable plasma CMV DNA.
Findings:
- Ganciclovir treatment followed by valganciclovir maintenance led to symptom improvement, enhanced MRI findings, and sustained undetectable CMV DNA in plasma.
- The case highlights diagnostic challenges in HIV patients with co-occurring cerebral conditions and the potential for CMV CNS replication independent of plasma viral load.
Implications:
- This case underscores the importance of considering CMV encephalitis in HIV-positive patients presenting with neurological deficits, even with multiple comorbidities.
- It highlights gaps in understanding optimal treatment durations and strategies for CMV CNS disease in immunocompromised individuals.
- The findings emphasize the need for CSF viral load monitoring in suspected cases, as plasma CMV DNA levels may not accurately reflect CNS viral activity.
Abstract:
Cytomegalovirus (CMV) central nervous system involvement is uncommon and hardly diagnosed because it can mimic many different conditions. We here present a case of an HIV-positive patient with neurological signs and symptoms (headache, asthenia, confusion, hallucinations, ataxia) with concurrent opportunistic diseases (neurotoxoplasmosis, disseminated Kaposi's sarcoma, disseminated CMV infection). CMV CNS involvement was not initially considered given the observed multiple comorbidities: antiviral treatment duration was probably not adequate given the end-organ disease. Concomitantly, plasma CMV DNA was undetectable while cerebrospinal fluid viral load was 31,340 copies/ml. Ganciclovir treatment followed by oral valganciclovir maintenance was associated with the slow disappearance of symptoms, the improvement of MRI images and the persistent undetectability of CMV DNA. The case here reported highlights the challenges of diagnosing CMV encephalitis in HIV-positive patients (with several cerebral comorbidities), the incomplete knowledge of the appropriate treatment for such a disease and the possibility of CMV replication in the cerebrospinal fluid despite undetectable plasma CMV DNA.
Related Concept Videos
Cytomegalovirus Disease
Encephalitis ll: Pathophysiology
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Encephalitis l: Introduction
Viral Meningitis
Arboviral Encephalitis

